Acquired
Novo Nordisk (Ozempic)
David Rosenthal
it's reaching other tissues in your body that normally GLP-1s wouldn't. And indications are showing that that is beneficial for those organs. So currently, Novo has clinical trials going for semaglutide, like same drug, same GLP-1s, use case in treating cardiovascular disease, in treating Alzheimer's, in treating kidney disease, many others.
0
💬
0
Comments
Log in to comment.
There are no comments yet.